pharmaceutical patents

When Does Eliquis Go Generic? The Full Timeline & What It Means for Patients

by
When Does Eliquis Go Generic? The Full Timeline & What It Means for Patients

The clock is ticking on Eliquis, one of the most prescribed blood thinners in the U.S., as its patent expires in 2024. When Eliquis transitions to a generic form—expected between late 2024 and early 2025—it could slash costs for millions of patients relying on apixaban for conditions like atrial fibrillation or deep vein thrombosis. But … Read more

When Will Eliquis Go Generic? The Race Against Time for Affordable Blood Thinners

by
When Will Eliquis Go Generic? The Race Against Time for Affordable Blood Thinners

The clock is ticking for Eliquis, one of the world’s most prescribed blood thinners. Since its FDA approval in 2012, apixaban (Eliquis’s generic name) has dominated the anticoagulant market, raking in over $10 billion annually for Bristol Myers Squibb (BMS) and Pfizer. But with its patent shield weakening, the question on every patient’s and insurer’s … Read more